Cluster Development Programme for the Pharma Sector/CDP-PS: Benefits
Cluster Development Programme for the Pharma Sector/CDP-PS: Benefits
Question: The Cluster Development Programme for the Pharma Sector(CDP-PS) has been formally launched recently. Discuss how this will benefit the pharmaceutical sector.
• The Cluster Development Programme for the Pharma Sector has been officially launched recently
• Programme will support the pharma industry to become capable, competitive and productive
• For the common man, availability, affordability and quality of medication is important and the CDP-PS will improve the health security of the country
• Clusters will ensure effective resting, training and affluent treatment facilities for the pharma industry
• CDP-PS will be implemented through PPP format
• Private sector will play a leading role in production of generic medication to help in holistic expansion
• It will also enhance competitiveness, easy access to standard testing facilities and value addition in the national pharmaceutical industry for SMEs especially through creation of world class facilities
• The existing infrastructure will also be strengthened to make the industry a leader in pharma exports
• The cost of production will be reduced by close to 20% in the clusters resulting in better availability and affordability of medicines in the national market
• The scheme will also assist the industry to meet the requirements of standards of the environment through innovative common waste management at low cost
• The scheme will also promote benefits arising on account of resource optimisation and economies of scale
Facts and Stats
• Towards the close of the financial year, 6 pharma sectors are likely to come up
• 3 of these will be green fields
• GoI will also come up with Bulk Drugs Parks
• Medical Devices Parks will also be established as part of CDP-PS
• Pharma industry is likely to grow by 14 to 15 percent per year and touch the figure of 4 lakh crore by 2020 according to some estimates
• INR 125 crores has been earmarked for CDP-PS in the 12th five year plan.